InspireMD Eyes US Launch Amid Revenue Growth
InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...
- Latest
- Trending
InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...
CES Energy Solutions posts $553.2M Q2 revenue, a 7% rise, plans growth via acquisitions and debt repayment.
ATSG reports strong Q2 2024 growth, raises EBITDA outlook, expands Amazon partnership with more aircraft.
Tom Lee believes the worst of market decline is over, yet investors still face growth worries. VIX and job data ...
Wintrust's Q2 2024 EPS falls short, revenue aligns with forecasts. Shares dip as net income declines by 1.6% from last ...
Ethereum holds strong as Mpeppe presale gains traction, promising potential gains for early investors in the evolving crypto scene.
Bitcoin's price soars to $60,557 in the USA as demand grows. Analysts predict a new ATH if key support levels ...
Nvidia's AI chip leadership is tested by new competitors like Alphabet and Apple, posing potential impacts on growth and market ...
Rivian's stock surges as cost reductions and efficiency gains boost its long-term prospects. Here's what investors need to know.
Foreign investors recently sold Japanese stocks, impacting market. Despite this, they're optimistic about the long-term market outlook.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.